Press Releases | Medtronic

Month Year

Email alerts

Feb 16, 2017

FDA Approves Expanded Indication for Medtronic Freezor® Xtra Cryoablation Catheter

Demonstrated Safe and Effective for Treating Patients with Abnormal Heart Rhythm of AVNRT

DUBLIN - Feb. 16, 2017 - Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has approved its Freezor® Xtra Cryoablation Catheter for treating patients with...
Feb 13, 2017

Medtronic Announces New, Outcome-Based Learning Program

Introduces New Approach to Healthcare Education and Development Focused on Outcomes That Matter to Patients

DUBLIN - Feb. 13, 2017 - Medtronic today announced the launch of Medtronic Impact in its Europe, Middle East & Africa region, which is part of the company's drive towards value-based healthcare...
Feb 13, 2017

Medtronic Expands Coronary Portfolio to Include New DxTerity(TM) Diagnostic Catheters and Suite of Tools for the Transradial Approach

Full Line of Innovative Transradial Products and Comprehensive Training Programs Reinforce Medtronic's Commitment to Optimizing the Treatment of Heart Disease

DUBLIN - Feb. 13, 2017 - Medtronic plc (NYSE: MDT) today announced that its market-leading coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line and several...
Feb 13, 2017

Medtronic EVP & President Michael J. Coyle to Speak at RBC Capital Markets Global Healthcare Conference

DUBLIN - Feb. 13, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the RBC Capital Markets 2017 Global Healthcare Conference on...
Feb 10, 2017

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2017

DUBLIN - Feb. 10, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its third quarter of fiscal year 2017 on Tuesday, February 21, 2017. A news release...
Feb 9, 2017

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

New Data Recently Presented at LINC 2017 Represents the First Presentation of Clinical Results Comparing a DCB to Angioplasty in Japan

DUBLIN - Feb. 9, 2017 - Medtronic plc (NYSE: MDT) today announced the one-year clinical outcomes from the MDT-2113 IN.PACT SFA Japan Trial. The data was recently presented by Osamu Iida, M.D.,...
Feb 6, 2017

Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors

Contract Award Continues Medtronic Care Management Services Veteran Support Initiated in 2011

DUBLIN - Feb. 6, 2017 - Medtronic plc (NYSE:MDT) today announced Medtronic Care Management Services (MCMS) is one of four vendors awarded a national contract from the U.S. Department of Veterans...
Feb 1, 2017

Medtronic CardioInsight Mapping Solution Cleared by FDA

System First Used Commercially in U.S. This Week

DUBLIN - Feb. 1, 2017 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CardioInsight(TM) Noninvasive 3D Mapping System. The CardioInsight...
Jan 26, 2017

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

DUBLIN - Jan. 26, 2017 - Medtronic plc (NYSE: MDT) today announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a study of the...
Jan 26, 2017

Medtronic Announces Medicare Coverage Decision for the First and Only Leadless Pacemaker Available for Use in the U.S.

CMS Decision Expands Patient Access to the Micra®Transcatheter Pacing System (TPS), the World's Smallest Pacemaker

DUBLIN - Jan. 26, 2017 - Medtronic plc (NYSE: MDT) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) will cover leadless cardiac pacemakers, as outlined in the...
Jan 25, 2017

Medtronic IN.PACT Admiral Drug-Coated Balloon Demonstrates Consistent Results in Asia and Belgium According to New Data Presented at LINC 2017

First Presentation of Results from Regional Cohorts of IN.PACT Global Study Reinforce Strong, Consistent and Safe Outcomes for PAD Patients

DUBLIN and LEIPZIG, Germany - Jan. 25, 2017 - Medtronic today presented new data at the Leipzig Interventional Course (LINC) 2017 conference supporting the IN.PACT® Admiral® drug-coated balloon...
Jan 24, 2017

Medtronic Announces CE Mark for New Lower Profile HawkOne 6F Directional Atherectomy System

Expands Treatment Options for Patients in Europe with Peripheral Artery Disease Both Above and Below the Knee

DUBLIN - Jan. 24, 2017 - Medtronic plc (NYSE: MDT) today announced CE (Conformité Européene) Mark approval for the HawkOne(TM) directional atherectomy system in a lower profile size for treating...
Jan 24, 2017

First Procedure Performed in Medtronic MRI-Guided Laser Ablation Trial to Treat Common Form of Epilepsy

DUBLIN - Jan. 24, 2017 - Medtronic plc (NYSE: MDT) announced today that the first procedure using the Visualase(TM) MRI-Guided Laser Ablation System has been performed in the pivotal SLATE...
Jan 17, 2017

Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies

Larger Device Offers Treatment to Patients Without a Previous TAVI Option

DUBLIN - Jan. 17, 2017 - Medtronic plc (NYSE:MDT) today announced the CE (Conformité Européenne) mark and European launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest sized...
Jan 3, 2017

Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference

DUBLIN - Jan. 3, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 35th Annual J.P. Morgan Healthcare Conference on Monday,...
Dec 21, 2016

Carousel Display of Multiple Assets

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et risus odio. Vivamus pellentesque, tortor a tempor semper, massa nulla placerat augue, sit amet convallis tellus orci ut massa....
Dec 21, 2016

Gallery Display of Multiple Assets

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et risus odio. Vivamus pellentesque, tortor a tempor semper, massa nulla placerat augue, sit amet convallis tellus orci ut massa....
Dec 21, 2016

Inline Display of Multiple Assets

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et risus odio. Vivamus pellentesque, tortor a tempor semper, massa nulla placerat augue, sit amet convallis tellus orci ut massa....
Dec 9, 2016

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2017

DUBLIN - Dec. 9, 2016 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2017 third quarter cash dividend of $0.43 per ordinary share, representing a 13 percent...
Dec 8, 2016

Medtronic EVP & President Hooman Hakami to Speak at Jefferies Diabetes Technology Summit

DUBLIN - Dec. 8, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Jefferies 2016 Diabetes Technology Summit on Monday, December...
Dec 7, 2016

Medtronic and Fitbit Partner to Integrate Health and Activity Data Into New CGM Solution for Simplified Type 2 Diabetes Management

New iPro(TM)2 myLog App Collects Data from Continuous Glucose Monitors (CGM) and Fitbit Activity Trackers, Provides Meaningful Insights on How Exercise Impacts Glucose Levels

DUBLIN and SAN FRANCISCO - Dec. 7, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and Fitbit (NYSE: FIT), the leader in the connected health and fitness market,...
Dec 6, 2016

Medtronic's Endurant(TM) II/IIs Stent Graft System Receives CE Mark for Use with ChEVAR Parallel Graft Technique

Medtronic is First and Only Company to Receive Approval for a ChEVAR Indication, Providing an Off-the-Shelf Option for Patients with Complex Aneurysms

DUBLIN – Dec. 6, 2016 – Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for the Endurant™ II/IIs stent graft system to treat abdominal aortic...
Dec 1, 2016

Medtronic Announces Reimbursement Approval and Launch of CoreValve(TM) Evolut(TM) R System in Japan

Medtronic Introduces First-and-Only Recapturable TAVI System Available in Japan

DUBLIN - Dec. 1, 2016 - Medtronic plc (NYSE: MDT) today announced it has received reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the recapturable,...
Nov 29, 2016

Medtronic First to Receive European Approval for Less-Invasive HVAD® Implant Procedure

New Implant Option Gives Physicians Surgical Alternative for Patients with Advanced Heart Failure

DUBLIN - Nov. 29, 2016 - Medtronic plc (NYSE: MDT) today announced that its HVAD® System left ventricular assist device (LVAD) received CE (Conformité Européenne) Mark for a less-invasive...
Nov 29, 2016

Medtronic Announces U.S. Launch of Integrated Health Solutions with University Hospitals Agreement

New Agreement Focuses on Improved System Efficiency at University Hospitals Cleveland Medical Center

DUBLIN and CLEVELAND - Nov. 29, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the signing of its first Integrated Health Solutions agreement in the...
Nov 22, 2016

Medtronic Reports Second Quarter Financial Results

Revenue of $7.3 Billion Grew 4% as Reported; 3% at Constant Currency

DUBLIN - November 22, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2017, which ended October 28, 2016. The company reported second...
Nov 17, 2016

New Data Show Medtronic Heli-FX EndoAnchor System Enhances Outcomes and Durability in Complex Aortic Disease

Data from ANCHOR Registry Demonstrate Applicability in Patients with Hostile Aortic Neck Anatomy

DUBLIN and NEW YORK - Nov. 17, 2016 - Medtronic plc (NYSE: MDT) today announced data demonstrating that the company's Heli-FX(TM) EndoAnchor(TM) system enhances outcomes and durability in patients...
Nov 16, 2016

Medtronic's Solitaire(TM) Stent Retriever Device Receives Expanded Indication from the U.S. Food and Drug Administration for the Reduction of Stroke-Related Disability

FDA Allows Use of the Most Studied Stent Retriever with IV-tPA

DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire(TM) stent retriever device....
Nov 16, 2016

Medtronic Releases FY16 Integrated Performance Report

Report Highlights Company's Global Financial, Social, and Environmental Impact

DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE:MDT) announces the release of its 2016 Integrated Performance Report. The report highlights - for the first time - the combined financial, social, and...
Nov 15, 2016

Medtronic's Endurant(TM) II/IIs Stent Graft System Delivers Positive Outcomes in Patients with Challenging Aortic Aneurysms

New Data from the Global ENGAGE Registry Builds on Durability of Endurant, with Strong Outcomes Out to Four Years in Patients with Standard and Hostile Neck Anatomies

DUBLIN - Nov. 15, 2016 - Medtronic plc (NYSE:MDT) today announced data supporting the strength and durability of the Endurant(TM) II/IIs1 stent graft system to treat abdominal aortic aneurysm...
Nov 14, 2016

Medtronic Receives FDA Approval for Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator

First CRT-D in U.S. to Help Improve Therapy Delivery in Heart Failure Patients Using Effective Pacing

DUBLIN - Nov. 14, 2016 - Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D)...
Nov 14, 2016

Medtronic to Unveil Data Supporting Endovascular Treatments for Aortic Disease at VEITHsymposium 2016

DUBLIN - Nov. 14, 2016 - Medtronic plc (NYSE: MDT) today announced notable presentations of clinical studies on how endovascular treatments are furthering the treatment of core and complex aortic...
Nov 11, 2016

Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2017

DUBLIN - Nov. 11, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its second quarter of fiscal year 2017 on Tuesday, November 22, 2016. A news release...
Nov 10, 2016

Medtronic Launches Orthopedic Solutions Business to Help Providers Deliver Outcome-Focused Care and Succeed in New Value-Based Bundled Service Models

Orthopedic Solutions Offers Comprehensive Services for Joint Replacement Episodes of Care, Including the Launch of a Total Knee Arthroplasty System

DUBLIN and DALLAS - Nov. 10, 2016 - Medtronic plc (NYSE: MDT) today announced the launch of Medtronic Orthopedic Solutions, a comprehensive offering for total joint replacement episodes of care...
Nov 1, 2016

Medtronic CoreValve(TM) Evolut R(TM) System Shows Exceptional Clinical Outcomes at One Year

New Data from Evolut R U.S. IDE study presented at TCT Reveals Positive Clinical Performance for the Recapturable TAVR Device, Including the First-of-its-Kind 34 mm Valve

DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) unveiled new clinical data showing that patients treated with the self-expanding CoreValve(TM) Evolut(TM) R System continued...
Nov 1, 2016

Medtronic Harmony(TM) Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year

FDA Approves IDE Study Initiation Following Positive Results from First-of-its-Kind Early Feasibility Study Presented at TCT

DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) today announced new clinical data for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study,...
Oct 31, 2016

New Data on Medtronic Evolut(TM) R TAVR System Show Excellent 'Real-World' Outcomes in Global Patient Population

Results from FORWARD and STS/ACC TVT Registry Demonstrate High Survival and Low Rate of All Stroke for Next-Generation TAVR Device in Everyday Clinical Practice

DUBLIN and WASHINGTON, DC - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) today presented new positive data from two large registries aimed at evaluating 30-day clinical performance outcomes for the...
Oct 31, 2016

First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes

Featured 'First Report' RevElution Trial at TCT Highlights the Potential Benefits of First-of-its-Kind Polymer-Free Technology with Controlled and Sustained Drug Delivery for Rapid Vessel Healing

DUBLIN and WASHINGTON, D.C. - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) unveiled today the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at the...
Oct 30, 2016

Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity(TM) DES

BIO-RESORT Demonstrates Excellent Clinical Outcomes for Medtronic Resolute(TM) Integrity(TM) DES, a Gold Standard for Percutaneous Coronary Intervention

DUBLIN and WASHINGTON, DC - Oct. 30, 2016 - Investigators today unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers analysis to compare the safety and...
Oct 27, 2016

The World Stroke Organization Road Map for Quality Stroke Care Has Been Launched

Medtronic joins the Global Framework for Stroke Care on World Stroke Day

DUBLIN and HYDERABAD, India - Oct. 27, 2016 - In recognition of World Stroke Day, Medtronic plc (NYSE:MDT) and the World Stroke Organization (WSO) joined together for the third year to raise...
Oct 26, 2016

Medtronic Announces FDA Approval of New Recaptureable TAVR System Available for Severe Aortic Stenosis Patients with Large Anatomies

Launch of 34 mm Self-Expanding Evolut R Device Expands TAVR Treatment to Patients Who Could Not be Treated Previously

DUBLIN - Oct. 26, 2016 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest...
Oct 24, 2016

MiniMed® Connect Mobile Accessory for Android Now Available from Medtronic

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns

DUBLIN - October 24, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of the Android(TM) operating system version of the...
Oct 24, 2016

Medtronic Receives FDA Clearance of New Lower Profile HawkOne 6F Directional Atherectomy System

New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee

DUBLIN - Oct. 24, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne(TM) Directional Atherectomy System in a new size for...
Oct 21, 2016

Medtronic to Webcast Investor and Analyst Briefings on October 26, 2016 and October 30, 2016

DUBLIN - Oct. 21, 2016 - Medtronic plc (NYSE:MDT) today announced the company will webcast investor and analyst briefings at two upcoming medical conferences. Medtronic will host a webcast to...
Oct 14, 2016

Medtronic Announces Voluntary Recall of Its Pipeline(TM) Embolization Device, Alligator(TM) Retrieval Device, X-Celerator(TM) Hydrophilic Guidewire, Ultraflow(TM) and Marathon(TM) Flow Directed Micro Catheters

DUBLIN - Oct. 14, 2016 - Medtronic plc (NYSE: MDT) today announced that it has notified customers of a voluntary recall of certain lots of its Pipeline(TM) embolization device, Alligator(TM)...
Oct 13, 2016

FIRE AND ICE Analysis: Lower Healthcare System Costs with Medtronic Cryoballoon

Late Breaking Clinical Trial Demonstrates Favorable Health Economics and Positive Clinical Outcomes for AF Patients

DUBLIN AND SEOUL, REPUBLIC OF KOREA - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) today unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon catheter ablation...
Oct 13, 2016

Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging

Patients with SureScan® Pacemakers, ICDs and CRT-Ds Now Can Receive 3 Tesla MRI Scans

DUBLIN - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and...
Oct 3, 2016

Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results

Presented at EACTS, First Data of New Pericardial Heart Valve Finds High Survival and Excellent Hemodynamics

DUBLIN and BARCELONA - Oct. 3, 2016 - Medtronic plc (NYSE: MDT) today announced positive clinical data for its investigational Avalus(TM) pericardial aortic surgical valve, intended for the...
Sep 30, 2016

FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls

DUBLIN - Sept. 30, 2016 - Medtronic plc (NYSE:MDT) announced today that two previously communicated global voluntary recalls related to the HeartWare International (HeartWare) HVAD® System have...
Sep 28, 2016

Medtronic Receives FDA Clearance of TrailBlazer Angled Peripheral Support Catheter

TrailBlazer Angled Support Catheter Broadens Medtronic's Leading Peripheral Options Adding Full Spectrum of Angled Resources to Meet Provider Needs

DUBLIN - September 28, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer(TM) angled support catheter for use in the...
Sep 28, 2016

Medtronic Receives FDA Approval for World's First Hybrid Closed Loop System for People with Type 1 Diabetes

The MiniMed® 670G System Features the Company's Most Advanced SmartGuard(TM) Algorithm To-Date

DUBLIN - Sept. 28, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed® 670G...
Sep 27, 2016

Medtronic Announces First Live Experience of Sugar.IQ with Watson for People Living with Diabetes

Sugar.IQ with Watson Cognitive App to Preview at Health 2.0 Conference

DUBLIN and SANTA CLARA, Calif. - Sept. 27, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that Sugar.IQ with Watson, the first-of-its-kind cognitive app...
Sep 26, 2016

Medtronic's StealthStation® Cranial Software Receives FDA Clearance as an Aid for Deep Brain Stimulation Lead Placement

The Company Continues to Pioneer Innovations in Deep Brain Stimulation and Surgical Technologies by Launching the Only Fully-Integrated Procedural Solution for Neurosurgery

DUBLIN and SAN DIEGO - September 26, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of StealthStation® Cranial Software as an aid for deep...
Sep 20, 2016

Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years

New Clinical Data Presented in Complicated Type B Aortic Dissection at VIVA 2016

DUBLIN and LAS VEGAS - Sept. 20, 2016 - Medtronic plc (NYSE: MDT) today announced new data, demonstrating safety and efficacy at three years in acute complicated Type B aortic dissection patients...
Sep 19, 2016

Analysis Shows Positive Association Between Cardiac Resynchronization Therapy and Patients' Increased Adherence to Heart Failure Medication Regimens

DUBLIN and ORLANDO, Fla. - Sept. 19, 2016 - Medtronic plc (NYSE:MDT) announced the results of an analysis that reveals patients increasingly adhere to heart failure medications after they receive...
Sep 19, 2016

New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate Durability, Safety and Efficacy for the Medtronic In.Pact Admiral DCB

Multiple, Rigorous Analyses Reinforce the Excellent Outcomes of IN.PACT Admiral Drug Coated Balloon and Differentiate it as Best-in-Class Treatment Option for PAD

DUBLIN and LAS VEGAS - September 19, 2016 - Medtronic today reinforced the superior durability, consistency, and safety of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral...
Sep 15, 2016

Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services

Dublin - September 15, 2016 - Medtronic (NYSE: MDT) today announced the appointment of Mark Ploof as Senior Vice President, Global Operations and Business Services effective October 31, 2016. He...
Sep 15, 2016

The Journal of the American Medical Association Publishes Medtronic's Hybrid Closed Loop System Pivotal Trial Results

DUBLIN - September 15, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of its Hybrid Closed Loop system pivotal trial results in the...
Sep 14, 2016

Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan

Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke

DUBLIN - Sept. 14, 2016 - Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac Monitor (ICM) System...
Sep 13, 2016

Medtronic Foundation Issues $250,000 in Health Access Grants to Support Local Diabetes Services in Northridge, California

Medtronic Foundation Grants Support Organizations Committed

NORTHRIDGE, Calif. - Sept. 13, 2016 - Medtronic Foundation today announced that five community organizations will receive a combined $250,000 in Health Access Grants in recognition of their...
Sep 13, 2016

Medtronic Receives FDA Approval of First Drug-Coated Balloon for Treatment of In-Stent Restenosis (ISR)

IN.PACT Admiral DCB Indication Expansion to Treat Patients with ISR

DUBLIN - Sept. 13, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment...
Sep 12, 2016

New ESC Guidelines Support Recent Medtronic Innovations for Patients with Atrial Fibrillation

Clinical Practice Guidelines from European Society of Cardiology 2016 Reinforce Benefits of Cryoballoon Ablation and Long-Term Cardiac Monitoring

DUBLIN - September 12, 2016 - Two Medtronic plc (NYSE: MDT) innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for...
Sep 8, 2016

Medtronic Recognized as a Sustainability Leader

Company named to the Dow Jones Sustainability North America Index (DJSI North America)

DUBLIN - September 8, 2016 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North...
Sep 6, 2016

Medtronic CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare Conference

DUBLIN - Sept. 6, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Morgan Stanley Global Healthcare...
Sep 1, 2016

Medtronic Announces Approval of Enlite® Sensor for iPro®2 Professional Continuous Glucose Monitoring System in the U.S.

iPro2 Professional CGM with Enlite Provides Critical Link Between Glucose Variability and Lifestyle for Improved Diabetes Control

DUBLIN - Sept. 1, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the FDA approval of the Enlitesensor for use with iPro2 Professional Continuous Glucose...
Sep 1, 2016

Medtronic EVP & RTG President Geoff Martha to Speak at Wells Fargo Global Healthcare Conference

DUBLIN - Sept. 1, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Wells Fargo Global Healthcare...
Aug 29, 2016

Medtronic Technologies Improve Delivery of Cardiac Resynchronization Therapy

First-of-its-Kind Data on EffectivCRT(TM) for Heart Failure Patients with Atrial Fibrillation Presented at ESC

DUBLIN and ROME - Aug. 29, 2016 - Medtronic plc (NYSE:MDT) today announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee) study. The study showed that the...
Aug 28, 2016

New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker

Results Featured at ESC 2016 Demonstrate Consistent, Sustained Safety and Effectiveness for the Medtronic Micra TPS

DUBLIN and ROME - AUGUST 28, 2016 - In the largest and longest clinical evaluation of leadless pacing patients to date, Medtronic plc (NYSE: MDT) today announced new long-term results from the...
Aug 26, 2016

Medtronic, on Behalf of Its Subsidiary Heartware International, Inc., Announces Offer to Repurchase HeartWare's 3.50% Convertible Senior Notes Due 2017 and 1.75% Convertible Senior Notes Due 2021

DUBLIN - Aug. 26, 2016 - Medtronic plc (NYSE: MDT), on behalf of its indirect, wholly-owned subsidiary HeartWare International, Inc., today announced that, in connection with the completion of the...
Aug 25, 2016

Medtronic Reports First Quarter Financial Results

Revenue of $7.2 Billion Decreased 1% as Reported; Prior Year Had Extra Selling Week

DUBLIN - August 25, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2017, which ended July 29, 2016. The company reported first quarter...
Aug 23, 2016

Medtronic Completes Acquisition of HeartWare International

Broadens Heart Failure Leadership Into Growing Circulatory Support Sector

DUBLIN - Aug. 23, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, has completed its acquisition of HeartWare International, Inc., a leading innovator of less-invasive,...
Aug 19, 2016

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2017

DUBLIN - August 19, 2016 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2017 second quarter cash dividend of $0.43 per ordinary share, representing a 13...
Aug 16, 2016

Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2017

DUBLIN - Aug 16, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter of fiscal year 2017, on Thursday, August 25, 2016. A news release will...
Aug 11, 2016

Medtronic Announces U.S. Launch of the MiniMed® 630G System with New User-Friendly Insulin Pump Design and SmartGuard(TM) Technology

DUBLIN - August 11, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA...
Aug 8, 2016

Medtronic Receives CE Mark for SureTune2(TM) for Deep Brain Stimulation Therapy

New Visual-Based Platform Helps Physicians Make Informed Programming Decisions by Providing an Intuitive Visualization of Patient-Specific Images and Data

DUBLIN - August 8, 2016 - Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for SureTune2(TM) software, which provides patient-specific visualization to...
Aug 1, 2016

Medtronic CoreValve(TM) Evolut(TM) R System First TAVI to Receive CE Mark for Intermediate Risk Aortic Stenosis Patients

Next-Generation Recapturable Device is the First-of-its-Kind Approved in Europe to Treat Intermediate Risk Patients as an Alternative to Open-Heart Surgery

DUBLIN - August 1, 2016 - Medtronic plc (NYSE: MDT) today announced CE (Conformité Européenne) mark for the self-expanding, recapturable and repositionable CoreValve(TM) Evolut(TM) R System to...
Jul 28, 2016

Medtronic Announces Beacon Heart Failure Management Service, Furthering Its Commitment to Delivering Value in Healthcare

New Service Integrates Medtronic Device Data with Remote Patient Monitoring Solutions

DUBLIN - June 28, 2016 - Medtronic plc (NYSE:MDT) today announced availability of its Beacon Heart Failure Management Service in the United States. This new service from Medtronic Care Management...
Jul 28, 2016

HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue

- Global revenue increased approximately 25% from first quarter of 2016

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
Jul 27, 2016

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

VIVA Sponsored REALITY Study Assessing Vessel Preparation and Treatment in Severe Calcified Lesions Expands to Germany; Principal Investigators Named; First Patient Enrolled

DUBLIN and SAN JOSE, Calif. -July 27, 2016 - Medtronic plc (NYSE: MDT) and VIVA Physicians today report the first patient enrolled in the REALITY Study. The VIVA sponsored study is assessing...
Jul 25, 2016

Medtronic Unveils VariLoc Variable Angle Locking Technology for Treatment of Fractures

DUBLIN and SHANGHAI - July 25, 2016 - Medtronic plc (NYSE: MDT) today announced the global launch of VariLoc Locking Compression Plate System in China and other select countries. With the...
Jul 20, 2016

Medtronic Receives First-Ever FDA Clearance for Cement-Augmented Pedicle Screws

Clearance Gives Spine Surgeons a New Treatment Option for Spinal Tumor Patients

DUBLIN - July 20, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the CD Horizon® Fenestrated Screw Set, which can be used for...
Jul 19, 2016

Medtronic Expands Continuous Glucose Monitoring (CGM) Solutions for People with Diabetes Using Insulin Injections with CE Mark Receipt

New Guardian(TM) Connect System Will Be Launched in Q2 FY17 Outside the U.S.

DUBLIN - July 19, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for its new Guardian(TM) Connect...
Jul 18, 2016

Medtronic Receives FDA Approval for Two-Level Prestige LP(TM) Cervical Disc Procedures

Two-Level Use of Prestige LP Cervical Disc Exhibited Statistical Superiority in Overall Success at 24 Months Compared to Patients Treated with Two-Level Fusion

DUBLIN - July 18, 2016 - Medtronic plc (NYSE: MDT) announced today the U.S. Food and Drug Administration's (FDA) approval of the Prestige LP(TM) Cervical Disc for the treatment of cervical disc...
Jul 15, 2016

Medtronic Launches Revamped Minimally Invasive Spine Fusion Procedures

Innovative Procedural Solutions Offer Efficiencies for Surgeons Using a Lateral Approach

DUBLIN - July 15, 2016 - Medtronic plc (NYSE: MDT) today announced the continued development of the OLIF Platform with the launch of the PivoxTM Oblique Lateral Spinal System with Lateral Plate...
Jul 15, 2016

Medtronic Foundation Calls for Applications for 2016 Bakken Invitation Award

International Award Honors the Philanthropic Power of Patients; At Least 10 Honorees Will Each Receive a $20,000 Grant Donated to an Eligible Charity Organization of Their Choice

DUBLIN - July 15, 2016 - The Medtronic Foundation is seeking applications for the 2016 Bakken Invitation Award - an international program honoring and connecting people who have overcome health...
Jul 13, 2016

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

Expanded Treatment Options for Patients with Longer SFA Lesions with Best-In-Class Drug-Coated Balloon Technology Now Available

DUBLIN - July 13, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in longer, 150 mm...
Jul 11, 2016

FDA Clears Expanded Indications for Medtronic NuVent(TM) EM Sinus Dilation System with Image Guidance

Clinical Study Conducted on Revision Subjects Support Expanded Indication for Patients with Previously Surgically Altered Tissue

DUBLIN - July 11, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of NuVent(TM), an EM sinus dilation system, for patients with scarred,...
Jun 27, 2016

Medtronic to Expand Heart Failure Portfolio with Acquisition of Heartware International

Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector

DUBLIN and FRAMINGHAM, Mass. - June 27, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of...
Jun 24, 2016

Medtronic Announces Double-Digit Increase in Cash Dividend; Reaches 40 Percent Payout Ratio

DUBLIN - June 24, 2016 - The board of directors of Medtronic plc (NYSE: MDT) today approved a 13 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.43 per ordinary...
Jun 23, 2016

World Stroke Organization and Medtronic Collaborate to Increase Stroke Awareness

The World Stroke Organization (WSO) today announced a global partnership with Medtronic plc (NYSE:MDT) to increase stroke awareness through several initiatives. The two organizations will work...
Jun 18, 2016

Material in Medtronic Leads Inducted into Space Technology Hall of Fame®

Medtronic Applied NASA Technology into Its Cardiac Devices

DUBLIN and COLORADO SPRINGS, COLO. - April 18, 2016 - The Space Foundation has inducted NASA Langley Research Center-Soluble Imide (LaRC-SI) - used in Medtronic plc (NYSE: MDT) leads connected to...
Jun 17, 2016

New Clinical Study Will Evaluate MRI-Guided Laser Ablation for a Common Form of Epilepsy

Drug-Resistant Mesial Temporal Lobe Epilepsy Is the Focus of Medtronic's SLATE Study

DUBLIN - June 17, 2016 - Medtronic plc (NYSE: MDT) announced today the U.S. Food and Drug Administration's (FDA) approval of the Investigational Device Exemption (IDE) application for the pivotal...
Jun 10, 2016

FIRE AND ICE Data Show Fewer Repeat Ablations and Hospitalizations for AF Patients Treated with Medtronic Cryoballoon

Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes

DUBLIN AND NICE, FRANCE - June 10, 2016 - Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of the FIRE AND ICE clinical trial that demonstrate significantly fewer...
Jun 10, 2016

Medtronic Converts 125 Million Patient Days of Data Into Personalized Insights That Improve Diabetes Management

CareLink® Portfolio Updates, IBM Watson Partnership Progress and New Strategic Alliances Delivering Intelligent Data and Actionable Information at ADA 2016

DUBLIN and NEW ORLEANS - June 10, 2016 - Delivering on its vision to transform care for the millions currently living with diabetes through intelligent data, Medtronic plc (NYSE:MDT) announced new...
Jun 9, 2016

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

DUBLIN and SIOUX FALLS, S.D. - February 9, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation's largest health...
Jun 9, 2016

New Data Further Demonstrate Safety Benefits for World's Smallest Pacemaker

Data Featured In Late-Breaking Trial Session at Cardiostim 2016 Show Micra TPS Safety Benefits Maintained Beyond Six Months

DUBLIN and NICE, FRANCE - JUNE 9, 2016 - Medtronic plc (NYSE:MDT) today announced new results from the Medtronic Micra® Transcatheter Pacing System (TPS) Global Clinical Trial in a late-breaking...
Jun 8, 2016

First Patient Treated with Medtronic Valiant Evo Thoracic Stent Graft System

Unique Next-Generation Device Evaluated in International Clinical Trial; First Procedure Performed at the University of Texas Health Science Center at Houston

DUBLIN and HOUSTON - June 8, 2016 - Medtronic plc (NYSE: MDT) and the University of Texas Health Science Center at Houston (UTHealth) today announced the first patient enrolled in a clinical study...
Jun 8, 2016

Medtronic Announces Results of Early Feasibility Studies Supporting New Approach to ICD Therapy During Cardiostim 2016

Places ICD Leads Under Rib Cage, Outside Heart and Veins

DUBLIN and NICE, FRANCE - JUNE 8, 2016 - Medtronic plc (NSYE: MDT) today announced results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator...
Jun 7, 2016

Medtronic to Unveil Pivotal Trial Results for Hybrid Closed Loop System at American Diabetes Association 2016 Meeting

DUBLIN - June 7, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 76th Scientific Sessions...
Jun 6, 2016

Medtronic Outlines Future Growth Vision at Investor Day

DUBLIN and NEW YORK CITY - June 6, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, shared during its Investor Day today in New York City an overview of the company's...

Show per page